赛隆药业集团股份有限公司 关于2026年第三次临时股东会增加 临时提案暨股东会补充通知的公告

Group 1 - The company, Sailong Pharmaceutical Group Co., Ltd., will hold its third extraordinary general meeting of shareholders on March 5, 2026, in Changsha, Hunan Province, combining on-site and online voting [1][3][5] - The meeting will discuss a temporary proposal to continue the public transfer of the equity of its wholly-owned subsidiary, Hunan Sailong Biopharmaceutical Co., Ltd., which was submitted by the controlling shareholder, Hainan Yayi Gongying Technology Partnership [2][4][9] - The company has set the record date for shareholders to attend the meeting as March 2, 2026 [6][7] Group 2 - The company will provide a network voting platform for shareholders through the Shenzhen Stock Exchange, allowing them to vote online during specified times on March 5, 2026 [5][17][25] - The company has previously attempted to publicly transfer 100% of the equity of Hunan Sailong Biopharmaceutical Co., Ltd. but did not find qualified buyers during the initial offering period [33][34] - The starting price for the upcoming public transfer of the subsidiary's equity will be set at 78.255 million yuan, reflecting a 10% reduction from the previous offering price [34][44]